101 related articles for article (PubMed ID: 9201971)
21. Lysine 5 and phenylalanine 9 of the factor IX omega-loop interact with phosphatidylserine in a membrane-mimetic environment.
Grant MA; Baikeev RF; Gilbert GE; Rigby AC
Biochemistry; 2004 Dec; 43(49):15367-78. PubMed ID: 15581349
[TBL] [Abstract][Full Text] [Related]
22. Profactor IX: the propeptide inhibits binding to membrane surfaces and activation by factor XIa.
Bristol JA; Freedman SJ; Furie BC; Furie B
Biochemistry; 1994 Nov; 33(47):14136-43. PubMed ID: 7947825
[TBL] [Abstract][Full Text] [Related]
23. Role of the propeptide and gamma-glutamic acid domain of factor IX for in vitro carboxylation by the vitamin K-dependent carboxylase.
Stanley TB; Wu SM; Houben RJ; Mutucumarana VP; Stafford DW
Biochemistry; 1998 Sep; 37(38):13262-8. PubMed ID: 9748333
[TBL] [Abstract][Full Text] [Related]
24. The entire gamma-carboxyglutamic acid- and helical stack-domains of human coagulation factor IX are required for optimal binding to its endothelial cell receptor.
Prorok M; Geng JP; Warder SE; Castellino FJ
Int J Pept Protein Res; 1996 Sep; 48(3):281-5. PubMed ID: 8897096
[TBL] [Abstract][Full Text] [Related]
25. Platelet physiology and thrombosis.
Andrews RK; Berndt MC
Thromb Res; 2004; 114(5-6):447-53. PubMed ID: 15507277
[TBL] [Abstract][Full Text] [Related]
26. The interaction of factor XIa with activated platelets but not endothelial cells promotes the activation of factor IX in the consolidation phase of blood coagulation.
Baird TR; Walsh PN
J Biol Chem; 2002 Oct; 277(41):38462-7. PubMed ID: 12167623
[TBL] [Abstract][Full Text] [Related]
27. Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain.
Bajaj SP; Sabharwal AK; Gorka J; Birktoft JJ
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):152-6. PubMed ID: 1729682
[TBL] [Abstract][Full Text] [Related]
28. The alpha1.alpha2 network of collagen IV. Reinforced stabilization of the noncollagenous domain-1 by noncovalent forces and the absence of Met-Lys cross-links.
Vanacore RM; Shanmugasundararaj S; Friedman DB; Bondar O; Hudson BG; Sundaramoorthy M
J Biol Chem; 2004 Oct; 279(43):44723-30. PubMed ID: 15299013
[TBL] [Abstract][Full Text] [Related]
29. The A-domain of integrin alpha 2 binds specifically to a range of collagens but is not a general receptor for the collagenous motif.
Tuckwell DS; Reid KB; Barnes MJ; Humphries MJ
Eur J Biochem; 1996 Nov; 241(3):732-9. PubMed ID: 8944759
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibody against chicken type IX collagen: preparation, characterization, and recognition of the intact form of type IX collagen secreted by chondrocytes.
Irwin MH; Silvers SH; Mayne R
J Cell Biol; 1985 Sep; 101(3):814-23. PubMed ID: 2411737
[TBL] [Abstract][Full Text] [Related]
31. Binding of coagulation factors IX and X to the endothelial cell surface.
Heimark RL; Schwartz SM
Biochem Biophys Res Commun; 1983 Mar; 111(2):723-31. PubMed ID: 6404275
[TBL] [Abstract][Full Text] [Related]
32. Binding domain for laminin on type IV collagen.
Rao CN; Margulies IM; Liotta LA
Biochem Biophys Res Commun; 1985 Apr; 128(1):45-52. PubMed ID: 3921025
[TBL] [Abstract][Full Text] [Related]
33. Binding of factors IX and IXa to cultured vascular endothelial cells.
Stern DM; Drillings M; Nossel HL; Hurlet-Jensen A; LaGamma KS; Owen J
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4119-23. PubMed ID: 6602986
[TBL] [Abstract][Full Text] [Related]
34. Identification of residues in the Gla-domain of human factor IX involved in the binding to conformation specific antibodies.
Wojcik EG; Cheung WF; van den Berg M; van der Linden IK; Stafford DW; Bertina RM
Biochim Biophys Acta; 1998 Jan; 1382(1):91-101. PubMed ID: 9507074
[TBL] [Abstract][Full Text] [Related]
35. Covalent cross-linking of the NC1 domain of collagen type IX to collagen type II in cartilage.
Eyre DR; Pietka T; Weis MA; Wu JJ
J Biol Chem; 2004 Jan; 279(4):2568-74. PubMed ID: 14602708
[TBL] [Abstract][Full Text] [Related]
36. A 48 kDa collagen-binding phosphoprotein isolated from bovine aortic endothelial cells interacts with the collagenous domain, but not the globular domain, of collagen type IV.
Yannariello-Brown J; Madri JA
Biochem J; 1990 Jan; 265(2):383-92. PubMed ID: 2154186
[TBL] [Abstract][Full Text] [Related]
37. The N-terminal epidermal growth factor-like domain of coagulation factor IX. Probing its functions in the activation of factor IX and factor X with a monoclonal antibody.
Persson KE; Villoutreix BO; Thämlitz AM; Knobe KE; Stenflo J
J Biol Chem; 2002 Sep; 277(38):35616-24. PubMed ID: 12105230
[TBL] [Abstract][Full Text] [Related]
38. Factor IX binding to collagen.
Gailani D
J Thromb Haemost; 2009 Nov; 7(11):1840-2. PubMed ID: 19694943
[No Abstract] [Full Text] [Related]
39. The fibril-associated collagen IX provides a novel mechanism for cell adhesion to cartilaginous matrix.
Käpylä J; Jäälinoja J; Tulla M; Ylöstalo J; Nissinen L; Viitasalo T; Vehviläinen P; Marjomäki V; Nykvist P; Säämänen AM; Farndale RW; Birk DE; Ala-Kokko L; Heino J
J Biol Chem; 2004 Dec; 279(49):51677-87. PubMed ID: 15383545
[TBL] [Abstract][Full Text] [Related]
40. Coagulation factor X-binding protein from Deinagkistrodon acutus venom is a Gla domain-binding protein.
Atoda H; Ishikawa M; Mizuno H; Morita T
Biochemistry; 1998 Dec; 37(50):17361-70. PubMed ID: 9860851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
